Ecliptasaponin A

Ecliptasaponin A
Product Name Ecliptasaponin A
CAS No.: 78285-90-2
Catalog No.: CFN93253
Molecular Formula: C36H58O9
Molecular Weight: 634.9 g/mol
Purity: >=98%
Type of Compound: Triterpenoids
Physical Desc.: Powder
Targets: TGF-β/Smad | COX | MMP(e.g.TIMP) | α-SMA | SOD
Source: The herbs of Eclipta prostrata.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $100/20mg
Ecliptasaponin A has protective effects against the pulmonary fibrosis induced by bleomycin via reducing the oxidative stress, lung tissue inflammation, and the subsequent epithelial-mesenchymal transition.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Food Res Int.2020, 133:109130.
  • Molecules.2018, 23(3):E615
  • Plants (Basel).2022, 11(21):2947.
  • Applied Biological Chemistry2023, 66:42.
  • Int J Mol Sci.2022, 23(23):14826.
  • Life Sci.2021, 270:119074.
  • Mol Med Rep.2015, 12(5):7789-95
  • J Drug Delivery Science and Tech.2022, 67:102957.
  • Molecules.2022, 27(19):6651.
  • JLiquid Chromatography & Related Tech.2021, 10826076.
  • Pulchinenoside E1

    Catalog No: CFN80305
    CAS No: 146100-02-9
    Price: Inquiry(manager@chemfaces.com)
    Dipsacussaponin C

    Catalog No: CFN95353
    CAS No: 152406-43-4
    Price: $318/5mg
    Pulchinenoside E2

    Catalog No: CFN80362
    CAS No: 244202-36-6
    Price: Inquiry(manager@chemfaces.com)
    Dipsacobioside

    Catalog No: CFN94827
    CAS No: 123350-57-2
    Price: Inquiry(manager@chemfaces.com)
    Gypsogenin

    Catalog No: CFN91485
    CAS No: 639-14-5
    Price: Inquiry(manager@chemfaces.com)
    Methyl gypsogenin 3-O-beta-D-glucuronopyranoside

    Catalog No: CFN90727
    CAS No: 96553-02-5
    Price: $138/20mg
    Bayogenin 3-O-beta-D-glucopyranoside

    Catalog No: CFN90996
    CAS No: 104513-86-2
    Price: $268/5mg
    Tenuifolin

    Catalog No: CFN98157
    CAS No: 20183-47-5
    Price: $100/20mg
    Raddeanoside 20

    Catalog No: CFN90659
    CAS No: 335354-79-5
    Price: $238/5mg
    Ciwujianoside B

    Catalog No: CFN99983
    CAS No: 114902-16-8
    Price: $218/20mg
    J Ethnopharmacol. 2015 Dec 4;175:172-80.
    Preventive effects of Ecliptae Herba extract and its component, ecliptasaponin A, on bleomycin-induced pulmonary fibrosis in mice.[Pubmed: 26385580 ]
    Ecliptae Herba, a nourishing traditional Chinese medicine, is also a folk medicine for the treatment of lung diseases. To investigate the anti-fibrosis effects and the underlying mechanism of the extract of Ecliptae Herba and its potential active components.
    METHODS AND RESULTS:
    The resulting extract (EXT) was prepared from the 80% ethanol extract of Ecliptae Herba. After intratracheally administrated with bleomycin (BLM, 5mg/kg), mice were orally treated with EXT at 2.5, 1.25, 0.625 g/kg and eclipta saponin A (ESA) at 80 mg/kg once daily for 28 day. The bodyweight, survival rate, pathological changes of lung and levels of hydroxyproline (HYP) were used to evaluate the anti-fibrotic effects. The malonaldehyde (MDA), superoxidae dismutase (SOD) activity, and the protein expressions of matrix metalloproteinase (MMP)-2, 9, tissue inhibitor of metalloproteinase-1 (TIMP-1), cyclooxygenase-2 (COX-2), α-smooth muscle actin (α-SMA) and transforming growth factor-β1 (TGF-β1) in lung tissue were analyzed by kits or western blot. Compared with BLM group, EXT administration could significantly ameliorated the pathological changes of lung, decreased the HYP content, enhanced the SOD activity, and reduced the MDA content of lung tissues. In mechanism, EXT significantly alleviated the levels of COX-2, TGF-β1, MMP-2 and α-SMA, as well as elevated the ratio value of MMP-9/TIMP-1. Additionally, the anti-fibrosis effects of ESA, a large amount of saponins isolated from Eclipta prostrata , was also evaluated by the BLM-induced model. The results showed that ESA could block BLM-induced histological changes of lung tissue and decrease the high levels of TGF-β1 and α-SMA.
    CONCLUSIONS:
    Ecliptae Herba has protective effects against the pulmonary fibrosis induced by BLM via reducing the oxidative stress, lung tissue inflammation, and the subsequent epithelial-mesenchymal transition. The active chemical constituents may be involved with triterpenoid saponins, such as ESA.
    ScientificWorldJournal. 2015;2015:980890.
    Qualitative and quantitative analysis of Eclipta prostrata L. by LC/MS.[Pubmed: 25667939 ]
    Eclipta prostrata L. is one of the Chinese medicinal tonics which are usually used for treating loose teeth, dizziness, tinnitus, hemoptysis, hematuria, and uterine bleeding. However, quality control of this herbal medicine has been not satisfactory.
    METHODS AND RESULTS:
    This study reported its qualitative and quantitative analyses based on LC/MS method. UHPLC-DAD-Q-TOF-MS fingerprinting and MS fragmentation cleavage pathway were investigated for qualitative analysis. Furthermore, a method for simultaneous quantitative determination of nine compounds, luteolin 7-O-β-D-glucopyranoside, ecliptasaponin C, luteolin, eclalbasaponin IV, apigenin, Ecliptasaponin A, echinocystic acid 28-O-β-D-glucopyranoside, echinocystic acid, and 3-oxo-16α-hydroxy-olean-12-en-28-oic acid in E. prostrata, was established. The method was validated for samples of E. prostrata from different habitats.
    CONCLUSIONS:
    The results showed good linear correlation, precision, accuracy, and repeatability that could be used for contents determination of the nine compounds in E. prostrata from different habitats.
    3,3',4',5,6,7,8-heptamethoxyflavone

    Catalog No: CFN95021
    CAS No: 1178-24-1
    Price: $268/10mg
    Ginsenoside F5

    Catalog No: CFN95034
    CAS No: 189513-26-6
    Price: $298/20mg
    (-)-Epiafzelechin 3-O-gallate

    Catalog No: CFN95081
    CAS No: 108907-43-3
    Price: $388/5mg
    Isocarlinoside

    Catalog No: CFN95092
    CAS No: 83151-90-0
    Price: $318/5mg
    Complanatoside C

    Catalog No: CFN95144
    CAS No: N/A
    Price: $318/5mg
    Arganine B

    Catalog No: CFN95281
    CAS No: 144425-21-8
    Price: $318/5mg
    4'-Hydroxy-5,7,3'-trimethoxyflavone

    Catalog No: CFN95398
    CAS No: 1239-68-5
    Price: $318/5mg
    Cajanine

    Catalog No: CFN95448
    CAS No: 87402-84-4
    Price: $318/5mg
    Giganteone A

    Catalog No: CFN95481
    CAS No: 460337-13-7
    Price: $318/5mg
    Schisphenlignan I

    Catalog No: CFN95586
    CAS No: 1542234-14-9
    Price: $318/5mg